Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AMPD2 antisense RNA 1 (AMPD2-AS1) is a long non-coding RNA (lncRNA) gene, not a protein, enzyme, transporter, or receptor[1]. Unlike AMPD2, which encodes a protein involved in purine metabolism, the function, molecular interactions, and clinical relevance of AMPD2-AS1 are currently poorly characterized in the scientific literature[1]. As a non-coding antisense RNA, it may have a regulatory role related to the expression of the AMPD2 gene or related pathways, but its function, disease associations, and potential as a therapeutic target remain undefined[1]. There is no evidence it is a therapeutic target, nor are there known drugs, biomarkers, or safety-related data. **Key context:** - The request appears to conflate AMPD2 (a well-studied enzyme and disease gene) with AMPD2-AS1, which is a non-coding RNA[1][3]. - AMPD2-AS1 is not a classic therapeutic target and is not functionally characterized as a receptor, enzyme, transporter, or similar class[1]. - Most resources (including GeneCards) list only sequence, genomic location, and basic transcript information for AMPD2-AS1, without biochemical data, interactors, or disease mechanisms[1]. If you are seeking information about the *protein-coding* gene AMPD2 (Adenosine monophosphate deaminase 2), which is involved in purine metabolism and disease, let me know and I can provide a fully structured answer for that protein target instead[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AMPD2 antisense RNA 1 (AMPD2-AS1).